Verticals/Pharma IT

Pharma IT

Where data integrity, automation and AI actually meet the plant floor.

Data integrityAutomationAICSA
AI Governance In Pharma: Is It Becoming The New GMP?Article
Lead story

AI Governance In Pharma: Is It Becoming The New GMP?

GMP built trust in physical manufacturing. Now algorithms need the same guardrails, here's why AI governance is following its playbook.

Simantini Singh Deo · Jul 29, 2026
Safety Data Was Never a Cost. AI Just Proved It.
Article

Safety Data Was Never a Cost. AI Just Proved It.

AI in Pharmacovigilance is unlocking value long buried in safety data, from drug repurposing to faster regulatory submissions.

Ashish Dwivedi · Sep 09, 2026
Building the Knowledge Foundations for AI-Ready Pharmaceutical Quality Systems
Article

Building the Knowledge Foundations for AI-Ready Pharmaceutical Quality Systems

How pharmaceutical quality systems can build the knowledge foundations needed for trustworthy AI across CMC and CGMP.

Dr. Ajaz Hussain · Sep 03, 2026
5 Considerations for Building a More Connected Digital QA/QC Laboratory
Article

5 Considerations for Building a More Connected Digital QA/QC Laboratory

Explore five key considerations for building a connected digital QA/QC laboratory, with practical insights on data integrity, integration, standardization, and AI readiness.

Vamsi Reddy · Aug 31, 2026
Audit Trail Review In Pharma Is The New FDA Finding, Not Existence
Article

Audit Trail Review In Pharma Is The New FDA Finding, Not Existence

FDA inspectors now ask who reviewed the audit trail, not just whether one exists, here's what's driving Audit Trail Review In Pharma citations.

Mrudula Kulkarni · Aug 29, 2026
Annex 22 Is Not Law Yet. What to Invest in Now
Article

Annex 22 Is Not Law Yet. What to Invest in Now

Annex 22 isn't law yet — this piece verifies its real EudraLex status and lays out the 7 investments pharma sites should fund now, regardless of the final date.

Mrudula Kulkarni · Aug 12, 2026
Rasayan Labs Emerges as a Unified AI Operating System for Generic Drug Development, Moving Beyond the Limits of Traditional Tools
Article

Rasayan Labs Emerges as a Unified AI Operating System for Generic Drug Development, Moving Beyond the Limits of Traditional Tools

Discover how Rasayan Labs is unifying AI-powered generic drug development with a single platform that accelerates API R&D, formulation, regulatory workflows, and more.

Team Pharma Now · Jul 30, 2026
Can AI Decode the Gut? : Machine Learning in Microbiome Research
Article

Can AI Decode the Gut? : Machine Learning in Microbiome Research

AI is decoding microbial patterns humans can't see. Here's how machine learning is transforming microbiome research into clinical reality.

Dr. Nalini Raghunathan · Jul 01, 2026
How ML Virtual Screening Is Scaling Cancer Drug Targets?
Article

How ML Virtual Screening Is Scaling Cancer Drug Targets?

ML virtual screening hits 18-45% in prospective trials vs sub-1% for HTS, unlocking undruggable cancer targets.

Mrudula Kulkarni · Jun 30, 2026
Schrodinger vs. Insilico Medicine: A Comparison Report
Article

Schrodinger vs. Insilico Medicine: A Comparison Report

Physics vs generative AI for cancer drug design. Schrodinger and Insilico Medicine compared pipeline, deals, and proof.

Mrudula Kulkarni · Jun 24, 2026